Work

POSTER: AML-643 Precision-Engineered Cell Therapy Orca-T Demonstrates High Relapse-Free Survival at 1 Year While Reducing Graft-Versus-Host Disease (GvHD) and Toxicity

Year: 2023

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)00488-3

Authors: Amandeep Salhotra, Caspian Oliai, Rasmus T. Hoeg, Arpita Gandhi, Lori Muffly, Samer A. Srour, Edmund Waller, Robert Lowsky, Sagar Patel, Bhagirathbhai Dholaria, Jeremy Pantin, Anna Pavlova, Nathaniel Fernhoff, James Scott McClellan, Mehrdad Abedi, Robert Negrin, Everett Meyer

Institutions: City Of Hope National Medical Center, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, University of California, Davis, Oregon Health & Science University, Stanford University, The University of Texas MD Anderson Cancer Center, Winship Cancer Institute, University of Utah, Huntsman Cancer Institute, Vanderbilt University Medical Center, Centennial Medical Center, Sarah Cannon

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4386277486

FWCI:

Cites:

Cited by:

Related to: 10